SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹23 Cr | ₹-5.96 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹-5.96 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2017 | ₹14 Cr |
How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | Positive | |
| Mar2024 | ₹-5.96 Cr | Negative | |
| Mar2023 | ₹11 Cr | -35.52 | |
| Mar2022 | ₹16 Cr | 17.98 | |
| Mar2017 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,268.1 Cr | -3.2% | -5.1% | -27.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.2% |
-5.1% |
-27.2% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses